Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Aker Carbon Capture ASA: Minutes of Annual General Meeting

The 2023 Annual General Meeting of Aker Carbon Capture ASA was held today as a digital meeting with online participation.All resolutions were made in accordance with the proposals set out in the meeting notice. Minutes of the meeting are attached and available on https://akercarboncapture.com/investors/general-meetings/.  The articles of association were amended in accordance with the proposal. Four members of the board of directors were re-elected in their current positions.  ENDS

Crunchfish at the Digital Euro Conference panel

Crunchfish participated at the Digital Euro Conference as a panellist in the CBDC technological choices session. In the recorded panel, Crunchfish CEO Joachim Samuelsson highlighted the importance for CBDCs to have survivability in the face of temporary failures on links and backend servers.    On March 31st, Crunchfish participated at the inaugural Digital Euro Conference  in Frankfurt as an exhibitor and as a panelist in the session CBDC

Resolutions adopted at SSAB’s 2023 AGM

SSAB’s annual general meeting (AGM) was held today, April 18, 2023, in Oxelösund. The shareholders were also able to exercise their voting rights by postal voting in accordance with the provisions of SSAB’s Articles of Association. The AGM resolved on a dividend of SEK 8.70 per share for the financial year 2022. Adoption of income statement and balance sheet The AGM adopted the income statement and balance sheet as well as the consolidated income statement and consolidated balance sheet. Allocation of result The AGM resolved on a dividend of SEK 8.70 per share for the

Report from Concentric AB’s annual general meeting on April 18, 2023

Concentric AB’s annual general meeting was held on Tuesday, April 18, 2023. The main resolutions passed were the following. Regarding full details of the resolutions, a referral is made to the notice convening the AGM and the complete proposals. The notice convening the AGM and the complete proposals are available at the company’s website, www.concentricab.com. Adoption of the income statements and the balance sheets The general meeting resolved to adopt the income statement and balance sheet and the consolidated income statement and consolidated balance sheet for the financial

#23-31 Nordic Growth Market NGM AB’s disciplinary committee issues a fine to Nexar Group AB

As of April 18, 2023, Nordic Growth Market NGM AB’s disciplinary committee has found that Nexar Group AB (“the Company”) has breached paragraph 4.1.1 in Rules for companies whose shares are listed on Nordic SME (“the Rulebook”) and therefore issued a fine of SEK 100 000 to the Company in accordance with chapter 5 of the Rulebook.Please see the attached decision from NGM’s disciplinary committee. For more information about this Market Notice, please contact us by e-mail, marketsurveillance@ngm.se or telephone, +46 8 566 390 55. NGM Market Notice Pressroomhttps://news.cision.com/ngm-

Eco Wave Power to Open First North American Subsidiary in New York City; Expands Presence in the United States

The move represents another strong commitment to Eco Wave Power’s focus on commercializing their technology in the United States and helping the country reach its ambitious climate goals. EWP-EDF One Project NEW YORK, New York (April 18, 2023) – Eco Wave Power Global AB (publ) (Nasdaq Capital Market: WAVE) (“Eco Wave Power” or the “Company”) announced today the opening of a U.S. subsidiary, under the name Eco Wave Power U.S. The Company plans to also establish a corporate office in New York City, which will be Eco Wave Power’s first office in the United States. The subsidiary

CHOSA Oncology AB payback of convertible loan in process

CHOSA Oncology AB has initiated the process of payback of the convertible loan of 14,98 mSEK (plus interest) which RhoVac obtained from shareholders to support the development of RV001 and which will be balanced by the EU grant from Horizon 2020. The process is unfortunately more complex than anticipated, which causes a delay. The payback is in process, and we expect to have it concluded within the coming week(s)CEO Peter Buhl comments: “The initiation process in ongoing but has unfortunately caused us more administrative challenges than we had hoped for. I want to apologize for any

Notification in accordance with the Finnish Securities Market Act Chapter 9 § 5: BlackRock, Inc.’s holding in Wärtsilä Corporation

Wärtsilä Corporation, Flagging notification, 18 April 2023 at 15:45 EESTNotification in accordance with the Finnish Securities Market Act Chapter 9 § 5: BlackRock, Inc.’s holding in Wärtsilä CorporationBlackRock, Inc. has informed Wärtsilä Corporation that it has crossed above the 5% disclosure limit on total holding in shares and voting rights on 17 April 2023. Following the transaction, BlackRock, Inc. owns 5.06% of Wärtsilä’s shares and voting rights, while its total holding in Wärtsilä Corporation corresponds to 5.18%. Total position of BlackRock, Inc. and its funds subject to the

“Energy Transition is a Global Challenge”: International Energy Summit will Focus on Key Topics and Challenges of the Energy Trilemma

The Association of International Energy Negotiators (AIEN) announces its next International Energy Summit (IES), to be held from May 30 to June 1 in Miami, Florida. The event will reflect the diverse needs of its membership and the wider energy community within a period of energy transition.Ricardo Silva, 2023-2024 AIEN President, says, “Over the past 12 months we have consolidated what we intended by widening the scope of the organization, moving from a pure focus on the oil & gas industry to meet the wider needs of our membership as they work towards energy transition. The summit in Miami

Truecaller reaches 350 million monthly active users

Truecaller, the leading global platform for verifying contacts and blocking unwanted communications, reached another significant milestone on April 17, when the number of monthly active users of the service reached over 350 million.“Reaching 350 million monthly active users is a major milestone that puts us on par with a handful of other global companies. After experiencing a period of somewhat slower growth in the beginning of the year, growth in the number of users has once again taken off. This has been achieved through improved organic growth without increased marketing spend. Growth is

Cline Scientific: Hanne Evenbratt to be elected as a member of the board

In order to further strengthen Cline's board, it is proposed that Dr. Hanne Evenbratt to be elected at tomorrow's annual general meeting as a member of the board. Hanne, responsible for technology and later project development, has been involved in the company's journey from an early stage and has extensive knowledge of both of the company's projects as well as the market in which they aim to be established. She is part of the company's management and is one of the major owners.See the bio below for more information about Hanne. Hanne Evenbratt is responsible for leadership in Cline's

Bulletin from the extraordinary general meeting in Cyxone AB on 18 April 2023

The English text is an unofficial translation. In case of any discrepancies between the Swedish text and the English translation, the Swedish text shall prevail. Today, on 18 April 2023, an extraordinary general meeting was held in Cyxone AB. A summary of the adopted resolutions follows below. All resolutions were adopted with the required majority.The extraordinary general meeting resolved, in accordance with the proposal from the Nomination Committee, that the board of directors shall compose of three board members for the time until the close of the next annual general meeting. It

Jobmatch Sweden now represented throughout Scandinavia – signs partnership with Danish Moving Talent

Jobmatch Sweden has now signed a partnership agreement with the Danish recruitment company Moving Talent, which will have the exclusive right to offer Jobmatch's DNV-certified organizational psychological test system on the Danish market. “Moving Talent is just the right partner for Jobmatch, they work with many different industries and deliver high quality candidates to their customers. The partnership is part of our continued expansion in Europe," says Klaus Olsen, CEO of Jobmatch Sweden.[Kenneth Oldenburg vd Moving Talent och Klaus Olsen vd Jobmatch Sweden] Kenneth Oldenburg, CEO

Asetek A/S – Updated key information relating to the Rights Issue

Aalborg, 18 April 2023. NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA, JAPAN OR SOUTH AFRICA OR IN ANY OTHER JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. Reference is made to the stock exchange announcement published by Asetek A/S (the “Company” or "Asetek") on 8 March 2023 relating to key information about a contemplated fully underwritten rights issue in the Company, to raise gross proceeds of approximately DKK 140 million (the “Rights Issue”). Updated

Veg of Lund continues international expansion

Veg of Lund launches DUG potato drink in 101 stores of Bilka and Føtex in Denmark this May.“Following our recent launch at Migros in Switzerland and entering the German market with our distributor CCP, this is another important step in our strategy of internationalisation and expansion. Bilka and Føtex are both leading retailers in Denmark and gives our DUG potato drink the exposure and positioning for further growth in the Danish market”, comments Fredrik Carling.   Salling Group is Denmark’s most diverse retail group, serving 11 million customers weekly and covering household chain

Asetek A/S – Publication of prospectus and terms of the fully underwritten Rights Issue

NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, CANADA, AUSTRALIA, OR JAPAN OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL. Asetek A/S (the "Company" or "Asetek") today announces the initiation of a rights issue (the "Rights Issue") at a subscription ratio of 1:1 and subscription price of NOK 3 per new share. The Rights Issue comprises 71,166,667 new shares, which are issued with preemptive rights to subscribe for the new shares for the Company's existing shareholders. This announcement is not a

ANNOUNCEMENT FROM SOTKAMO SILVER AB AGM ON APRIL 18, 2023

Press release: Stockholm, April 18, 2023, 12:15 CET   The following main decisions were made at the AGM: The income statement and the balance sheet for both the parent company and the group regarding the financial year 2022 were adopted by the AGM. The AGM decided that no dividend would be paid out for the financial year 2022. The members of the Board and the CEO were granted discharge from liability for the financial year 2022. The AGM decided that the Board would comprise of six ordinary members without deputy directors. Jarmo Vesanto, Kimmo Luukkonen, Eeva-Liisa Virkkunen,

Orkla ASA – Issuance of Commercial Paper

Orkla ASA has issued a new commercial paper of NOK 600,000,000.Start date:                   21 April 2023 Maturity:                     15 May 2023 Coupon:                      3.55 % Organised by:             Handelsbanken Capital Markets     Orkla ASA Oslo, 18 April 2023     Ref.: Senior Vice President Group Treasury Geir Solli Tel.: +47 995 42 789

Gedea Biotech obtains US-patent covering pHyph for antibiotic-free treatment and prevention of bacterial vaginosis

· Important expansion of patent estate in the largest market for vaginal bacterial infections · pHyph has shown superior safety profile, a cure rate in line with antibiotics and a lower infection recurrence rate Lund, Sweden, April 18, 2023. Swedish women’s health company Gedea Biotech announced today that the United States Patent and Trademark Office (USPTO) has granted the company´s patent application 16/753,899 directed to gluconic acid derivatives for preventing and/or treating bacterial infections. The patent number is US 11,612,584 and the patent can be kept in force until 2038.

Moberg Pharma Annual report for 2022

Moberg Pharma´s Annual report for 2022 has been published and is available on www.mobergpharma.seFor additional information, please contact:Anna Ljung, VD, phone: +46 707 66 6030, e-mail: anna.ljung@mobergpharma.seMark Beveridge, CFO, phone: +46 76 805 82 88, e-mail: mark.beveridge@mobergpharma.se About this informationThis information is information that Moberg Pharma AB (publ.) is obliged to make public in accordance with the Securities Market Act. The information was submitted for publication, through the contact persons set out above at 12.00 p.m (noon) CET on April 18, 2023.

Karolinska University Hospital welcomed as new site in expansion of Horizon 2020 project DeteCTCs

Stockholm, Sweden – April 18, 2023 – iCellate is excited to announce the expansion of the Horizon 2020 project, DeteCTCs, to Sweden with the addition of clinical site Karolinska University Hospital led by principal investigator Matthias Löhr. The DeteCTCs project is led in collaboration with QIAGEN and University Medical Center Schleswig-Holstein.iCellate, QIAGEN, and University Medical Center Schleswig-Holstein were awarded 2.4 million euro from European Funding Agency, Horizon 2020 in February 2021. The ongoing project aims to make iCellate’s CTC platform CellMate® available to cancer

Nordic Nanovector Publishes Data from the PARADIGME Phase 2 Clinical Trials with Betalutin® on European Clinical Trials Database

Oslo, Norway,18 April 2023 Nordic Nanovector ASA (OSE: NANOV) (“Nordic Nanovector” or the “Company”) announces that full results from its Phase 2 clinical trials of Betalutin® (177Lu lilotomab satetraxetan) in resistant/refractory (R/R) indolent non-Hodgkin’s lymphoma (NHL) have been published at EudraCT, the European Union Drug Regulating Authorities Clinical Trials Database (the database for all interventional clinical trials on medicinal products submitted to the National Competent Authorities (NCAs) of the European Union). The data from the Phase 1b/2a LYMRIT 37-01 and the Phase 2b

Nitro Games to adopt the IFRS in financial reporting

Nitro Games Oyj has decided to adopt the International Financial Reporting Standards (IFRS) in its financial reporting. Previously, the company has prepared its financial statements and interim financial reports in accordance with the Finnish Accounting Standards (FAS). The company's transition date to the IFRS reporting is January 1, 2022. In connection with the first published quarterly report for 2023, Nitro Games Oyj will disclose the comparative figures for 2022 in accordance with the IFRS standard, together with the details of the impact and key differences to the Finnish

There are no items matching the current filter
There are no more items matching the current filter
Back to top